According to the new market research report "Cell Lysis Market by Product (Consumables (Reagents, Enzymes, Detergent), Instruments (Sonicator, Homogenizer), Type of Cell (Microbial, Mammalian), End User (Research Laboratories, Biopharmaceutical & Biotechnology Companies) - Global Forecastx", published by MarketsandMarkets™, report provides a detailed overview of the major drivers, restraints, challenges, opportunities, current market trends, and strategies impacting the Cell Lysis Market along with the estimates and forecasts of the revenue and market share analysis.
The Global Cell Lysis Market is expected to reach USD 3.84 Billion, at a CAGR of 10.3%.
Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=260138321
The major factor driving the growth of this market are increasing government funding for research, high prevalence of diseases, expanding biotechnology and biopharmaceutical industries, and growing focus on personalized medicine
The report segments this Cell Fractionation Market based on product, type of cell, end-users, and regions. Among the various product, the consumables segment is expected to account for the largest share of the market. The consumables market includes reagents and kits, beads, and disposables. Reagents and kits are further classified into enzymes, detergent solutions, and other reagents and kits. Enzymes segment is projected to grow at the highest CAGR from 2016 to 2021. The high growth of enzymes segment can be attributed to the increasing investments for cell-based research.
Browse and in-depth TOC on "Cell Lysis Market"
84 - Tables
41 - Figures
135 - Pages
On the basis of type of cell, the Cell Lysis Market is segmented into mammalian cells, microbial cells, and other cells. The mammalian cells segment is expected to account for the largest share of the global market in 2016. Rising aging population and increasing need for development of new cell therapies are the key factors propelling the growth of this market.
End-users, included in the Cell Fractionation Market are research laboratories and institutes, biopharmaceutical and biotechnology companies, and others. The research laboratories and institutes segment are expected to account for the largest share of the global market in 2016. High incidence of diseases and research investments in life sciences is driving the growth of this market.
Get 10% Customization on this Research Report: https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=260138321
Based on regions, the global market is segmented into North America, Europe, Asia, and the Rest of the World (RoW). North America is expected to account for the largest share of the market during the forecast period. Growth in this regional segment is driven by factors such as increase in aging population, and increasing government funding in North America.
Key players in the Cell Lysis Market include Beckman Coulter, Inc. (U.S.), Becton, Dickinson and Company (U.S.), Bio-Rad Laboratories, Inc. (U.S.), Cell Signaling Technology, Inc. (U.S.), F. Hoffman-La Roche AG (Switzerland), Merck KGaA (Germany), Miltenyi Biotec (Germany), QIAGEN N.V. (Netherlands), Qsonica, LLC. (U.S.), and Thermo Fisher Scientific Inc. (U.S.).
The Research Report Consist of 135 pages, which covers Global Cell Lysis Market overview, Major Key Players detailed Analysis, market opportunities, market risk, forecast for the next five years, major driving factors for the market as well as detailed analysis for CAGR, scope, research findings, leading key players marketing strategy to acquire major market in the form of revenue.The cell lysis consists of various products that are used for extraction of nucleic material, proteins and other cell content.
This market is driven by several factors such as increasing government funding for research, high prevalence of diseases, expanding biotechnology and biopharmaceutical industries, and growing focus on personalized medicine.
High potential growth in emerging markets has opened an array of opportunities for the market.
However, high cost of cell-based research and shortage of skilled personnel are hampering the growth of the global market.The Global Cell Lysis Market is expected to reach USD 3.84 Billion, at a CAGR of 10.3%.Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=260138321 Major Market Drivers for Cell Lysis: Increasing Government Funding for ResearchHigh Prevalence of DiseasesExpanding Biotechnology and Biopharmaceutical IndustriesGrowing Focus on Personalized MedicineMarket Segmentation: This research report segments the Cell Lysis Market on basis of product, type of cell, end-users.Based on product, the Cell Fractionation market is segmented into consumables and instruments.
Consumables include reagents and kits, beads, and disposables.
Reagents and kits are further classified into enzymes, detergent solutions, and other reagents and kits.
The global Cell & Gene Therapy Manufacturing Services Market research report, published by Value Market Research, is designed to offer various market framework such as market size, portion, trends, growth path, value and factors that impact the current market dynamics over the forecast period 2020-2027.
Most importantly, this report also provides the latest significant strategies adopted by major players along with their market share.The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide.
The major players in the cell & gene therapy manufacturing services market include AGC Biologics, Ajinomoto Bio-Pharma Services, Anemocyte, Astellas, BioNTech IMFS, Boehringer Ingelheim BioXcellence, Bristol Myers Squibb, Catalent, Cognate BioServices/CRL, Cytiva, and Cytovance Biologics.
This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.Get more information on "Global Cell & Gene Therapy Manufacturing Services Market Research Report" by requesting FREE Sample Copy at https://www.valuemarketresearch.com/contact/cell-gene-therapy-manufacturing-services-market/download-sampleMarket DynamicsFactors such as the high prevalence of cancer and chronic diseases, increasing spending in pharmaceutical & biological research, and increasing collaboration among companies and CDMOs are primarily driving the growth of the global cell & gene therapy manufacturing services market.
Cell and gene therapies offer potential promise to treat and relieve life-threatening diseases.
Pharmaceutical companies are more usually outsource their research CDMOs or CROs to focus on core activities.
